ACON

Insider trade Purchase by Scott Breidbart

20d ago

Insider trade Purchase by David K Neal

21d ago

Insider trade Purchase by Brent Ness (Chief Executive Officer)

21d ago

Insider trade Purchase by William Wesemann

24d ago

News Aclarion announces $2.5M stock repurchase plan

41d ago

SEC filing ACON Adopts Limited Duration Stockholder Rights Plan, Expires 1 Year, 10% Trigger, $14 Exercise Price

75d ago

News Aclarion Raises $10.4 Million, Sharpens Focus On Nociscan Rollout

140d ago

News Aclarion Strengthens Balance Sheet and Extends Cash Runway Into 2028

140d ago

News Aclarion to enroll around 25% of patients in CLARITY trial by Q2

145d ago

News Aclarion Provides 2025 Update and 2026 Corporate Outlook

145d ago

News Aclarion Announces First Patient Enrollments at Two Additional CLARITY Trial Sites and Provides Guidance on Expected Availability of Initial Data

147d ago

News Aclarion Announces Use of MR Spectroscopy for identifying Biomarkers of Discogenic Pain highlighted at Global Neuroscience Conference

153d ago